PREVYMIS (LETERMOVIR)

**Product type:** Human Prescription Drug

**Active ingredient:** LETERMOVIR

**Strength:** 20 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Merck Sharp & Dohme LLC

**Marketing category:** NDA (NDA209940)

**Pharmacologic class:** Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]